REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study) (RECREATE Pilot)
An International Multicentre Randomized Controlled Trial of Intensive Insulin Therapy Targeting Normoglycemia In Acute Myocardial Infarction: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Pilot Study
Sponsor: Population Health Research Institute
Listed as NCT00640991, this PHASE3 trial focuses on Cardiovascular Diseases and Hyperglycemia and remains completed. Sponsored by Population Health Research Institute, it has been updated 7 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Apr 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Population Health Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Adrogué, Argentina , Bangalore, India , Calicut, India , Chennai, India , Dt. Dibrugarh, India , Hamilton, Canada , Kottayam, India , Mumbai, India , Nagpur, India , Raipur, India and 3 more locations